emerg
respiratori
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
pose
potenti
biolog
threat
human
sar
mer
manifest
sever
atyp
pneumonia
associ
high
morbid
mortal
human
major
studi
carri
sarscovinfect
human
anim
attribut
dysregulatedexuber
innat
respons
lead
contributor
sarscovmedi
patholog
decad
sar
epidem
approv
prevent
therapeut
agent
avail
case
reemerg
sarscov
relat
virus
strong
neutral
antibodi
respons
gener
spike
glycoprotein
sarscov
complet
protect
suscept
host
howev
neutral
antibodi
titer
memori
b
cell
respons
short
live
sarsrecov
patient
antibodi
target
primari
homolog
strain
interestingli
acut
phase
sar
human
associ
sever
reduct
number
cell
blood
surprisingli
limit
number
studi
explor
role
cellmedi
adapt
immun
respons
respiratori
coronaviru
pathogenesi
review
discuss
role
antiviru
cell
respiratori
coronaviru
infect
special
emphasi
emerg
coronavirus
coronavirus
belong
famili
coronavirida
envelop
positivesens
singlestrand
rna
virus
coronaviru
genom
approxim
kb
make
virus
largest
known
rna
virus
yet
identifi
coronavirus
infect
varieti
host
includ
human
sever
vertebr
coronavirus
associ
sever
respiratori
intestin
tract
infect
respiratori
coronavirus
long
recogn
signific
pathogen
domest
companion
anim
caus
upper
respiratori
tract
infect
human
thu
sever
human
coronavirus
hcov
etiolog
agent
mild
respiratori
ill
includ
common
cold
croup
eg
hcovhku
human
coronavirus
sarscov
merscov
also
associ
sever
respiratori
ill
coronavirus
induc
respiratori
tract
diseas
vertebr
anim
includ
mous
hepat
natur
mous
pathogen
infecti
bronchiti
viru
ibv
chicken
avian
speci
bovin
coronaviru
bcov
cow
rumin
porcin
respiratori
syndrom
viru
prcv
pig
canin
respiratori
coronaviru
crcov
dog
name
coronavirus
induc
mild
respiratori
ill
gener
preval
younger
popul
human
domest
anim
respons
sever
diseas
sarscov
merscov
caus
lethal
diseas
age
immunocompromis
individu
notabl
except
ibv
sever
form
upper
respiratori
tract
infect
young
chick
respons
croup
children
epidem
sarscov
infect
result
overal
mortal
surviv
observ
young
year
old
sarscovinfect
patient
mortal
rate
elderli
individu
age
date
newli
emerg
merscov
infect
peopl
death
sever
report
sar
outbreak
indic
acut
respiratori
distress
syndrom
ard
develop
major
patient
sever
diseas
ard
nonspecif
endstag
process
patient
pulmonari
diseas
caus
varieti
etiolog
agent
sever
elderli
individu
result
mortal
among
elderli
sar
patient
patholog
investig
patient
lethal
sar
reveal
acut
pulmonari
edema
extens
inflammatori
cell
infiltr
multiorgan
failur
thromboembol
complic
septicemia
sever
lung
system
inflamm
believ
result
cytokin
dysregul
patient
sar
increas
level
cytokin
tnfa
like
contribut
poor
outcom
exuber
innat
cytokin
respons
attribut
hyperactiv
macrophagemonocyt
lineag
cell
addit
increas
level
type
interferon
ifn
dysregul
interferonstimul
gene
isg
respons
observ
patient
sever
sar
overal
still
known
whether
sar
human
result
primarili
type
ifnindepend
exagger
proinflammatori
reaction
whether
ifndepend
ifnindepend
aberr
cytokin
product
contribut
sever
patholog
similar
sar
human
merscovinfect
patient
exhibit
symptom
flulik
ill
follow
atyp
pneumonia
includ
fever
dri
cough
sever
short
breath
howev
still
know
much
innat
adapt
immun
respons
merscovinfect
individu
mainli
small
number
sporad
mer
case
report
date
pauciti
clinic
data
absenc
autopsi
inform
investig
sarscov
pathogenesi
sever
anim
model
develop
soon
sar
epidem
mice
cat
ferret
use
anim
model
studi
sar
pathogenesi
human
isol
sarscov
could
replic
host
follow
intranas
infect
contrast
sar
human
overt
clinic
sign
observ
cat
ferret
show
evid
mild
diseas
similarli
mice
infect
human
urbani
strain
sarscov
develop
mild
diseas
although
diseas
sever
greater
age
mice
sever
nonhuman
primat
also
experiment
infect
sarscov
variabl
diseas
sever
depend
upon
primat
model
use
despit
variat
age
nonhuman
primat
associ
exacerb
innat
immun
respons
acut
lung
injuri
similar
human
although
without
associ
lethal
lack
use
anim
model
mimick
human
diseas
sever
laboratori
develop
mouseor
ratadapt
strain
sarscov
caus
extens
lethal
pulmonari
diseas
one
mouseadapt
strain
sarscov
extens
use
pathogenesi
studi
induc
sever
diseas
young
balbc
age
mice
week
strain
infect
age
mice
induc
robust
upregul
proinflammatori
cytokin
tnfa
chemokin
furthermor
comparison
young
mice
infect
age
mice
month
associ
sever
reduct
number
virusspecif
cell
lung
sinc
cell
requir
control
exuber
innat
immun
respons
absenc
potent
antiviru
cell
respons
age
host
could
lead
exacerbateddysregul
innat
respons
patholog
addit
virusspecif
cell
play
critic
role
clear
viru
elimin
virusinfect
cell
sever
studi
human
anim
identifi
discuss
host
innat
respons
sarscov
respiratori
coronavirus
despit
extens
effort
limit
inform
avail
role
antigenspecif
cellmedi
immun
respons
respiratori
coronavirus
review
focu
cellmedi
immun
respons
sarscov
major
studi
address
cell
respons
respiratori
viru
infect
come
mice
infect
varieti
natur
mouseadapt
pathogen
studi
use
natur
mous
pathogen
sendai
viru
mous
parainfluenza
type
pathogen
mous
hepat
commonli
mouseadapt
stain
human
pathogen
apuerto
wsn
strain
influenza
use
studi
innat
adapt
immun
respons
initi
immun
respons
invad
pathogen
begin
direct
infect
airway
epithelium
follow
initi
infect
lungresid
respiratori
dendrit
cell
rdc
acquir
invad
pathogen
antigen
infect
epitheli
cell
becom
activ
process
antigen
migrat
drain
mediastin
cervic
lymph
node
dln
dln
rdc
present
process
antigen
form
mhcpeptid
complex
circul
cell
follow
engag
cell
receptor
tcr
peptidemhc
complex
addit
costimulatori
signal
cell
becom
activ
prolifer
vigor
migrat
site
infect
fig
site
infect
activ
virusspecif
effector
cell
produc
antivir
cytokin
ifnc
tnfa
chemokin
cytotox
molecul
perforin
granzym
b
effector
cytokin
ifnc
directli
inhibit
viral
replic
enhanc
antigen
present
chemokin
produc
activ
cell
recruit
innat
adapt
cell
control
pathogen
burden
cytotox
molecul
granzym
b
directli
kill
infect
epitheli
cell
help
elimin
pathogen
despit
wealth
inform
cell
respons
mani
respiratori
pathogen
less
known
respiratori
coronaviru
infect
acut
phase
sar
human
patient
associ
mark
leukopenia
sever
lymphopenia
patient
involv
dramat
loss
cell
patient
cell
patient
comparison
healthi
control
individu
subsequ
studi
show
impair
cell
activ
sarscovinfect
patient
determin
express
cell
subset
sever
sarscov
infect
human
character
delay
develop
adapt
immun
respons
prolong
viru
clearanc
addit
leukopenia
associ
lymphopenia
also
observ
mer
patient
albeit
lesser
degre
observ
sar
patient
detail
clinic
studi
show
mer
patient
leukopen
patient
lymphopenia
decreas
number
cell
strongli
correl
sever
acut
phase
sar
diseas
human
although
sarscov
known
product
infect
cell
alter
antigen
present
cell
apc
function
impair
dc
migrat
result
reduc
prime
cell
like
contribut
fewer
number
virusspecif
cell
lung
possibl
explan
cell
lymphopenia
includ
exuber
type
ifn
respons
high
level
glucocorticoid
result
normal
stress
respons
might
induc
cell
apoptosi
current
much
less
known
fate
cell
merscovinfect
patient
sever
hlaa
cell
recogn
sarscov
epitop
identifi
pbmc
sarsrecov
individu
immunogen
epitop
local
spike
nucleocapsid
n
protein
sarscov
use
elispot
intracellular
ifnc
express
assay
follow
peptid
stimul
directli
ex
vivo
addit
sever
cell
epitop
also
identifi
character
protein
sarscov
pbmc
sar
survivor
howev
hla
restrict
known
subsequ
lv
et
al
demonstr
immun
transgen
mice
recombin
dna
rdna
vaccin
encod
protein
induc
peptid
ifnc
releas
target
cell
lysi
cell
sever
sarscov
specif
cell
epitop
identifi
infectedrecov
human
pbmc
date
studi
identifi
antigenspecif
cell
sarscovinfect
recov
patient
one
studi
cell
specif
epitop
nucleocapsid
n
protein
identifi
sar
survivor
studi
librati
et
al
detect
hladr
restrict
cell
epitop
protein
recov
patient
result
show
n
protein
sarscov
contain
immunogen
epitop
recogn
cell
sinc
protein
sarscov
capabl
induc
neutral
antibodi
respons
n
protein
elicit
cell
respons
human
protein
use
potenti
vaccin
candid
abl
gener
strong
humor
cellmedi
immun
respons
sarscov
one
caveat
immun
vaccin
encod
n
protein
induc
eosinophil
respons
vaccin
need
monitor
care
inform
epitop
recogn
patient
mer
current
avail
identif
virusspecif
cell
epitop
mice
one
first
studi
yang
et
al
demonstr
exist
sarscovspecif
cell
mice
immun
recombin
dna
rdna
encod
protein
stimul
pool
overlap
speptid
antigenspecif
cell
detect
ifnc
express
subsequ
sever
studi
identifi
sarscovspecif
cell
mice
immun
rdna
recombin
viru
encod
n
protein
detail
list
sarscovspecif
immunodomin
cell
epitop
identifi
mice
provid
tabl
identif
relev
cell
epitop
merscov
hinder
absenc
recent
mous
model
infect
dipeptidylpeptidas
identifi
function
merscov
receptor
human
mous
function
receptor
result
mice
impervi
merscov
infect
recent
zhao
et
al
show
balbc
mice
sensit
merscov
infect
transduct
express
follow
merscov
infect
sever
brestrict
cell
epitop
detect
protein
mice
restrict
cell
epitop
local
n
protein
balbc
mice
infect
murin
coronaviru
induc
sever
lung
patholog
aj
mice
follow
infect
virusspecif
cell
identifi
suscept
resist
strain
mice
use
direct
ex
vivo
stimul
splenocyt
infect
mice
sever
individu
overlap
peptid
ifnc
product
detect
flow
cytometri
mice
immunodomin
ia
b
restrict
cell
epitop
local
protein
b
restrict
cell
epitop
found
protein
similarli
mice
cell
epitop
ie
k
restrict
found
n
protein
domin
cell
epitop
n
protein
viru
clearanc
primari
respons
viru
infect
influenza
parainfluenza
clearli
depend
virusspecif
cell
rapid
viru
clearanc
correl
magnitud
cell
respons
although
sever
sarscovspecif
cell
detect
infectedrecov
patient
mice
studi
address
role
virusspecif
cell
sarscov
pathogenesi
studi
use
balbc
mice
chen
et
al
show
intranas
inocul
monthold
balbc
mice
sarscov
urbani
strain
induc
interstiti
pneumon
diffus
alveolar
damag
studi
deplet
cell
cell
delay
viru
clearanc
enhanc
immunemedi
interstiti
pneumon
deplet
cell
also
result
reduc
neutral
antibodi
titer
lung
sarscov
urbani
infect
mice
sinc
urbani
strain
sarscov
induc
nonleth
selflimit
diseas
protect
role
virusspecif
cell
could
describ
studi
hand
infect
young
balbc
mice
mouseadapt
strain
sarscov
induc
sever
diseas
gener
poor
virusspecif
cell
respons
poor
virusspecif
cell
respons
attribut
ineffici
immun
activ
particularli
respiratori
dc
rdc
shown
reduc
express
mhcii
cell
harvest
lung
activ
rdc
revers
inhibitori
mechan
deplet
inhibitori
alveolar
macrophag
treat
mice
poli
c
result
greater
number
antiviru
cell
lung
ultim
correl
better
protect
subsequ
direct
evid
role
virusspecif
cell
sarscov
clearanc
host
protect
came
adopt
transfer
studi
one
studi
zhao
et
al
adopt
transfer
sarscovspecif
effector
cell
separ
immunodefici
scid
ragmic
suscept
young
balbc
mice
transfer
sarscovspecif
cell
mice
result
rapid
viru
clearanc
amelior
clinic
diseas
increas
number
virusspecif
cell
vivo
immun
dc
also
result
robust
cell
respons
acceler
viru
clearanc
increas
surviv
challeng
balbc
mice
although
adopt
transfer
sarscovspecif
effector
cell
control
sarscov
lung
still
known
whether
natur
vivo
gener
virusspecif
cell
would
equal
protect
advanc
age
human
anim
becom
highli
suscept
sarscov
respiratori
viru
infect
agedepend
increas
suscept
associ
signific
reduct
magnitud
virusspecif
cell
respons
young
wk
mice
gener
sarscovspecif
cell
respons
approxim
eightfold
greater
observ
mice
reduct
number
sarscovspecif
cell
lung
age
mice
attribut
part
impair
abil
rdc
migrat
dln
prime
suffici
number
antigenspecif
cell
even
though
impair
migrat
rdc
dln
agedepend
phenomenon
much
pronounc
age
mice
infect
sarscov
compar
infect
respiratori
virus
influenza
viru
respiratori
syncyti
viru
rsv
migrat
rdc
dln
requir
express
express
rdc
inhibit
prostaglandin
turn
increas
lung
mice
age
even
increas
howev
sarscov
infect
local
pharmacolog
inhibit
receptor
specif
antagonist
bw
result
enhanc
migrat
rdc
dln
subsequ
augment
sarscovspecif
cell
respons
lung
associ
enhanc
surviv
age
mice
import
note
howev
partial
protect
demonstr
surviv
observ
antagonist
bw
treat
sarscovinfect
age
mice
result
suggest
ageassoci
factor
impair
one
compon
innat
adapt
arm
immun
system
also
like
contribut
deficit
observ
similar
sarscovspecif
cell
merscovspecif
cell
also
play
import
role
clear
merscov
balbc
mice
recent
studi
infect
cell
tcra
defici
mice
merscov
result
persist
merscov
lung
viru
clear
control
mice
follow
merscov
infect
number
virusspecif
cell
peak
day
postinfect
lung
merscovinfect
wt
balbc
mice
addit
effector
cell
specif
immunedomin
epitop
mice
balbc
mice
effici
kill
peptidepuls
target
cell
vivo
although
transduct
subsequ
merscov
sensit
limit
studi
clearli
demonstr
import
virusspecif
cell
clear
merscov
describ
earlier
infect
respiratori
tract
induc
pulmonari
patholog
suscept
aj
mice
unlik
sarscovspecif
cell
vivo
deplet
cell
suscept
aj
mice
primari
infect
significantli
amelior
diseas
sever
improv
airway
function
suggest
cell
induc
overt
lung
patholog
aj
mice
thu
unlik
sarscovinfect
mice
cell
respons
appar
excess
mice
contrast
infect
lead
signific
weight
loss
persist
lung
liver
spleen
brain
later
stage
infect
day
postinfect
intranas
infect
suscept
mice
gener
robust
broad
virusspecif
cell
respons
wherea
resist
mice
antigenspecif
cell
respons
domin
resist
display
mice
probabl
entir
due
greater
virusspecif
cell
equal
robust
cell
respons
b
snj
mice
associ
signific
morbid
result
consist
obtain
infect
mice
neurotrop
jhm
strain
mhv
mhvjhm
infect
induc
encephalomyel
acut
chronic
demyelin
mice
virusspecif
cell
play
critic
role
viral
clearanc
cell
provid
necessari
help
antivir
function
cell
interestingli
mhvjhmspecif
cell
requir
distinct
effector
mechan
control
viru
replic
differ
cell
type
cn
instanc
perforinmedi
cytolysi
crucial
control
viru
replic
microgliamacrophag
viru
clearanc
oligodendrocyt
requir
ifnc
depend
effector
function
adopt
transfer
antigenspecif
cell
infect
mice
lack
b
cell
ragi
induc
cn
demyelin
show
cell
respons
requir
viru
clearanc
immunopatholog
mice
cell
thu
contribut
morbid
studi
anoth
coronaviru
induc
hepat
necrosi
mice
show
effect
cell
respons
amelior
diseas
balanc
determin
resist
suscept
aj
balbc
mice
respect
result
suggest
role
virusspecif
primari
cell
respons
respiratori
coronaviru
infect
viru
mous
strain
depend
furthermor
interest
know
whether
lung
patholog
aj
hej
mice
due
imbal
andor
cell
respons
shown
respiratori
viru
infect
rsv
unrel
coronaviru
infect
ibv
infect
one
lead
caus
respiratori
ill
young
chick
infect
young
chick
gray
strain
ibv
induc
sand
n
proteinspecif
cell
respons
adopt
transfer
virusspecif
effector
cell
isol
spleen
postinfect
chick
greatli
reduc
clinic
ill
rapidli
clear
viru
lung
comparison
receiv
cell
result
show
coronavirusspecif
cell
also
protect
set
effector
phase
immun
respons
follow
sharp
contract
number
antigenspecif
cell
virusspecif
cell
undergo
apoptosi
contract
phase
follow
memori
phase
stabl
pool
memori
cell
maintain
prolong
period
time
memori
cell
program
counter
subsequ
infect
relat
pathogen
mount
rapid
respons
reexposur
pathogen
question
minim
requir
costimulatori
signal
well
establish
memori
cell
uniqu
anatom
distribut
function
mainten
respons
recal
recent
advanc
highlight
key
role
virusspecif
tissueresid
memori
cell
effect
counter
local
pathogen
challeng
tissueresid
memori
cell
well
equip
gener
rapid
recal
respons
locat
site
infect
possess
potent
lytic
activ
granzym
b
express
tissueresid
memori
cell
secret
cytokin
ifnc
chemokin
activ
innat
cell
attract
memori
cell
peripheri
follow
respiratori
tract
infect
memori
cell
resid
lung
airway
lung
interstiti
tissu
lung
airway
contain
high
proport
antigenspecif
cell
comparison
lung
interstiti
tissu
convers
lungairwayresid
memori
cell
lack
constitut
cytolyt
activ
prolifer
situ
howev
cell
constantli
replenish
circul
recruit
cell
circul
depend
express
although
difficult
address
human
recent
studi
highlight
import
virusspecif
memori
cell
patient
respiratori
diseas
thu
sridhar
et
al
show
presenc
memori
cell
correl
protect
recent
epidem
caus
strain
influenza
viru
howev
understand
virusspecif
memori
cell
lung
deriv
experiment
studi
use
either
influenza
sendai
viru
mice
term
patient
sar
sever
studi
identifi
virusspecif
memori
cell
patient
recov
infect
long
four
year
acut
infect
one
studi
cell
specif
hlaa
epitop
spike
protein
identifi
surviv
patient
one
year
postinfect
virusspecif
cell
produc
high
level
effector
cytokin
ifnc
tnfa
cytotox
molecul
perforin
granzym
b
peptid
stimul
vitro
memori
cell
specif
epitop
within
protein
sarscov
also
identifi
recov
individu
use
pool
overlap
peptid
n
e
proteinspecif
cell
identifi
pbmc
sarsrecov
individu
postinfect
virusspecif
cell
mainli
exhibit
central
memori
phenotyp
wherea
memori
cell
effector
memori
cell
phase
clinic
trial
vaccin
healthi
individu
rdna
encod
spike
protein
sarscov
elicit
neutral
antibodi
spikeproteinspecif
cell
respons
major
sarscov
spikeproteinspecif
cell
cell
subject
minor
subject
detect
spike
proteinspecif
cell
respons
subject
collect
studi
suggest
potenti
role
virusspecif
memori
cell
broad
longterm
protect
sarscov
infect
import
neutral
ab
memori
b
cell
respons
sarscov
declin
significantli
year
postinfect
also
strain
specif
similar
human
studi
analysi
experiment
anim
demonstr
presenc
sarscovspecif
cell
follow
rdna
vaccin
recombin
viru
immun
intramuscular
immun
rhesu
macaqu
recombin
adenoviru
encod
sarscovn
protein
follow
booster
vaccin
day
induc
nspecifict
cell
respons
immun
mice
rdna
vaccin
encod
n
e
protein
sarscov
induc
virusspecif
memori
cell
virusspecif
memori
cell
abl
produc
effector
cytokin
eg
ifnc
cytolyt
molecul
upon
vitro
peptid
stimul
although
sever
group
demonstr
presenc
sarscovspecif
memori
cell
studi
demonstr
vivo
potenti
clear
viru
one
studi
deplet
virusspecif
memori
cell
balbc
mice
immun
rdna
encod
protein
effect
viru
clearanc
day
postchalleng
howev
caveat
studi
urbani
strain
larg
nonpathogen
mice
use
author
examin
effect
cell
deplet
viru
clearanc
later
time
point
virusspecif
effector
memori
cell
would
expect
exert
antivir
function
anoth
studi
ohno
et
al
identifi
hlaa
sarscovnspecif
ctl
infect
hlaa
transgen
mice
use
surfacelink
liposom
peptid
ctlbase
vaccin
sarscov
infect
surfacelink
liposom
peptid
deriv
n
protein
effect
induc
ctl
respons
upon
challeng
immun
mice
rapidli
clear
vaccinia
viru
vv
express
sarscovn
unpublish
studi
demonstr
protect
role
sarscovsspecif
memori
cell
follow
lethal
sarscov
infect
mice
studi
intraven
dcpeptid
immun
follow
intranas
boost
recombin
vaccinia
viru
encod
gener
larg
pool
memori
cell
lung
mice
virusspecif
memori
cell
lung
provid
partial
signific
protect
lethal
sarscov
challeng
data
suggest
virusspecif
memori
cell
enhanc
kinet
viru
clearanc
protect
suscept
host
lethal
sarscov
infect
howev
protect
effect
observ
natur
infect
suggest
role
antiviru
cell
antiviru
antibodi
provid
optim
protect
contrast
adopt
transfer
memori
cell
bulk
memori
splenocyt
purifi
memori
cell
isol
spleen
enhanc
morbid
mortal
mice
lung
patholog
mice
possibl
due
robust
ifnc
proinflammatori
cytokin
product
even
subleth
dose
infect
gener
greater
magnitud
virusspecif
cell
respons
anoth
possibl
absenc
immun
serum
b
cell
respons
virusspecif
memori
cell
provid
complet
protect
mice
infect
neurotrop
mhvjhm
strain
antigenspecif
memori
cell
gener
immun
rvv
express
immunodomin
cell
epitop
follow
cn
mhvjhm
challeng
cell
exhibit
rapid
recal
lymphoid
organ
rapidli
recruit
cn
increas
number
facilit
effici
mhvjhm
clearanc
cn
memori
virusspecif
cell
also
protect
infect
ibv
infect
chick
adopt
transfer
memori
cell
isol
spleen
week
post
ibv
infect
protect
young
chick
lethal
ibv
infect
studi
memori
cell
show
cytolyt
activ
vitro
assay
complet
clear
ibv
lung
kidney
although
limit
amount
data
avail
virusspecif
memori
cell
respons
emerg
coronavirus
exist
studi
indic
lung
resid
virusspecif
memori
cell
provid
substanti
protect
follow
sarscov
challeng
review
discuss
current
understand
virusspecif
cellmedi
immun
respons
respiratori
coronavirus
sever
line
evid
respiratori
viru
infect
influenza
parainfluenza
establish
virusspecif
cell
gener
primari
memori
respons
abl
clear
viru
protect
host
lethal
infect
contrari
virusspecif
cell
respons
respiratori
coronavirus
abil
clear
viru
depend
type
pathogen
question
host
use
studi
case
mice
infect
sarscov
virusspecif
cell
absenc
antibodi
cell
respond
viru
provid
partial
signific
level
protect
effect
viru
clearanc
hand
cell
detriment
induc
lung
patholog
suscept
aj
mice
followup
studi
patient
recov
sar
suggest
sarscovspecif
antibodi
respons
short
live
patient
sarscovspecif
igm
iga
respons
last
less
month
virusspecif
igg
titer
peak
fourmonth
postinfect
markedli
declin
year
despit
lack
virusspecif
memori
b
cell
respons
sarscovspecif
memori
cell
persist
sarsrecov
patient
year
postinfect
consist
human
studi
result
anim
studi
also
suggest
strong
virusspecif
cell
respons
requir
protect
mice
lethal
infect
futur
vaccin
intervent
also
consid
strategi
enhanc
cell
respons
provid
robust
longterm
memori
sinc
tissueresid
memori
cell
provid
better
protect
boost
local
system
memori
cell
respons
would
use
strategi
either
intervent
alon
